$LIDR
AEye, Inc.

2023 Q3 Form 10-Q Financial Statement

#000181864423000010 Filed on August 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $188.0K $571.0K
YoY Change -75.49% -19.12%
Cost Of Revenue $4.479M $1.911M
YoY Change 65.4% 33.92%
Gross Profit -$4.291M -$1.340M
YoY Change 121.07% 85.85%
Gross Profit Margin -2282.45% -234.68%
Selling, General & Admin $7.290M $8.949M
YoY Change -41.03% -40.93%
% of Gross Profit
Research & Development $5.654M $5.897M
YoY Change -36.97% -45.21%
% of Gross Profit
Depreciation & Amortization $328.0K $336.0K
YoY Change -0.91% 31.76%
% of Gross Profit
Operating Expenses $12.94M $14.85M
YoY Change -39.32% -42.71%
Operating Profit -$17.24M -$16.19M
YoY Change -25.95% -39.23%
Interest Expense $366.0K $185.0K
YoY Change 4.27% -62.32%
% of Operating Profit
Other Income/Expense, Net $192.0K $174.0K
YoY Change -156.97% -5.43%
Pretax Income -$17.04M -$16.01M
YoY Change -27.82% -39.46%
Income Tax $5.000K $19.00K
% Of Pretax Income
Net Earnings -$17.05M -$16.03M
YoY Change -27.84% -39.43%
Net Earnings / Revenue -9068.09% -2807.53%
Basic Earnings Per Share -$0.09 -$0.09
Diluted Earnings Per Share -$0.09 -$0.09
COMMON SHARES
Basic Shares Outstanding 184.8M shares 176.9M shares
Diluted Shares Outstanding 184.1M shares 175.7M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $45.89M $58.65M
YoY Change -59.09% -53.36%
Cash & Equivalents $37.15M $18.39M
Short-Term Investments $8.743M $40.26M
Other Short-Term Assets $171.0K $109.0K
YoY Change -19.34% -49.07%
Inventory $4.868M $4.913M
Prepaid Expenses $2.635M $1.728M
Receivables $238.0K $290.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $55.51M $67.15M
YoY Change -54.63% -50.32%
LONG-TERM ASSETS
Property, Plant & Equipment $7.787M $7.783M
YoY Change 2.18% 15.87%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.040M $6.235M
YoY Change -62.03% 467.85%
Total Long-Term Assets $25.37M $28.77M
YoY Change -10.52% 10.0%
TOTAL ASSETS
Total Short-Term Assets $55.51M $67.15M
Total Long-Term Assets $25.37M $28.77M
Total Assets $80.88M $95.92M
YoY Change -46.33% -40.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.707M $3.520M
YoY Change 300.6% -8.24%
Accrued Expenses $7.247M $9.020M
YoY Change -26.71% -16.42%
Deferred Revenue $18.00K $150.0K
YoY Change -98.81% -90.81%
Short-Term Debt $0.00 $1.641M
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $11.97M $14.33M
YoY Change -45.81% -11.87%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $82.00K $44.00K
YoY Change -84.17% -4.35%
Total Long-Term Liabilities $82.00K $44.00K
YoY Change -84.17% -4.35%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.97M $14.33M
Total Long-Term Liabilities $82.00K $44.00K
Total Liabilities $27.54M $30.26M
YoY Change -30.58% -10.28%
SHAREHOLDERS EQUITY
Retained Earnings -$309.9M -$292.8M
YoY Change 36.64% 44.14%
Common Stock $19.00K $18.00K
YoY Change 18.75% 12.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $53.34M $65.66M
YoY Change
Total Liabilities & Shareholders Equity $80.88M $95.92M
YoY Change -46.33% -40.54%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$17.05M -$16.03M
YoY Change -27.84% -39.43%
Depreciation, Depletion And Amortization $328.0K $336.0K
YoY Change -0.91% 31.76%
Cash From Operating Activities -$9.058M -$15.25M
YoY Change -59.59% -10.76%
INVESTING ACTIVITIES
Capital Expenditures $611.0K $209.0K
YoY Change -137.19% -121.22%
Acquisitions
YoY Change
Other Investing Activities $31.91M $13.87M
YoY Change -52.63% 29.22%
Cash From Investing Activities $31.30M $13.66M
YoY Change -52.38% 40.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.323M -2.670M
YoY Change -112.08% -769.17%
NET CHANGE
Cash From Operating Activities -9.058M -15.25M
Cash From Investing Activities 31.30M 13.66M
Cash From Financing Activities -1.323M -2.670M
Net Change In Cash 20.92M -4.259M
YoY Change -61.45% -38.64%
FREE CASH FLOW
Cash From Operating Activities -$9.058M -$15.25M
Capital Expenditures $611.0K $209.0K
Free Cash Flow -$9.669M -$15.46M
YoY Change -53.45% -4.01%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
175675994 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
175675994 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
157310419 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
157310419 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
168962722 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
168962722 shares
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15611000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26649000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-41407000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-52586000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
93970000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6513000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
391000 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
867000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1755000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
469000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-26265000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
75966000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4110000 usd
CY2023Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
181000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1254000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
118000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
420000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-16031000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
65656000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
168767000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5340000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
222000 usd
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1149000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-1056000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-24881000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
147243000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6557000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
446000 usd
CY2022Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1431000 usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1422000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-182000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-26467000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
127588000 usd
us-gaap Net Income Loss
NetIncomeLoss
-51348000 usd
us-gaap Depreciation
Depreciation
666000 usd
us-gaap Depreciation
Depreciation
463000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
52000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
706000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
654000 usd
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
47000 usd
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
0 usd
us-gaap Inventory Write Down
InventoryWriteDown
544000 usd
us-gaap Inventory Write Down
InventoryWriteDown
335000 usd
lidr Gain Loss On Fair Value Of Convertible Note And Warrant Liabilities
GainLossOnFairValueOfConvertibleNoteAndWarrantLiabilities
-926000 usd
lidr Gain Loss On Fair Value Of Convertible Note And Warrant Liabilities
GainLossOnFairValueOfConvertibleNoteAndWarrantLiabilities
109000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
10623000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
11897000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
65000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-826000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-327000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4033000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2502000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1316000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2884000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-900000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
2164000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-411000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
282000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
932000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-785000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1354000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-749000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-859000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-837000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1285000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
808000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1759000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
96000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
35850000 usd
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
26234000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
35138000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
24475000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
391000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
668000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1051000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3400000 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
4973000 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1422000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
118000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5515000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1310000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2822000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-9947000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18392000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6386000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
10000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
10000 usd
us-gaap Interest Paid Net
InterestPaidNet
106000 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
48000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
562000 usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
3009000 usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 usd
lidr Tax Withholding Accrued Share Based Payment Arrangement
TaxWithholdingAccruedShareBasedPaymentArrangement
1000 usd
lidr Tax Withholding Accrued Share Based Payment Arrangement
TaxWithholdingAccruedShareBasedPaymentArrangement
15000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
556000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-bottom:0.12pt;padding-left:0.23pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:0.12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments which potentially subject the Company to concentration of credit risk consist primarily of cash, cash equivalents, and marketable securities, and accounts receivable. The Company places its cash and cash equivalents with major financial institutions, which management assesses to be of high credit quality, to limit the exposure of each investment. The Company’s marketable securities have investment grade ratings when purchased which mitigates risk.</span></div><div style="margin-bottom:0.12pt;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s accounts receivables are derived from customers located in the U.S., Europe, and Asia. The Company mitigates its credit risks by performing ongoing credit evaluations of its customers’ financial conditions. The Company generally does not require collateral.</span></div>
CY2023Q2 lidr Class Of Warrant Or Right Term Of Contract
ClassOfWarrantOrRightTermOfContract
P4Y
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2150000 usd
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
8713000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
7982000 usd
lidr Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Income Expense
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherIncomeExpense
931000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
21000 usd
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1683000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18392000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19064000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18392000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21214000 usd
CY2023Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2035000 usd
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2022000 usd
CY2023Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2823000 usd
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2484000 usd
CY2023Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
55000 usd
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
47000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
4913000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
4553000 usd
CY2023Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
3089000 usd
CY2022Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
1491000 usd
CY2023Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
592000 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
833000 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1728000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4203000 usd
CY2023Q2 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
1351000 usd
CY2022Q4 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
984000 usd
CY2023Q2 lidr Demonstration Units Current
DemonstrationUnitsCurrent
109000 usd
CY2022Q4 lidr Demonstration Units Current
DemonstrationUnitsCurrent
281000 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
109000 usd
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
0 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
713000 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3297000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6181000 usd
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
602000 usd
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
600000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
1204000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
1178000 usd
CY2023Q2 us-gaap Variable Lease Cost
VariableLeaseCost
80000 usd
CY2022Q2 us-gaap Variable Lease Cost
VariableLeaseCost
52000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
159000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
115000 usd
CY2023Q2 us-gaap Lease Cost
LeaseCost
682000 usd
CY2022Q2 us-gaap Lease Cost
LeaseCost
652000 usd
us-gaap Lease Cost
LeaseCost
1363000 usd
us-gaap Lease Cost
LeaseCost
1293000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1262000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2570000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2583000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2660000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2701000 usd
CY2023Q2 lidr Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
11116000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
22892000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
4505000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
18387000 usd
CY2023Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
5000 usd
CY2022Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
7000 usd
CY2023Q2 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
47000 usd
CY2022Q2 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
0 usd
CY2023Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
3089000 usd
CY2022Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
1491000 usd
CY2023Q2 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
902000 usd
CY2022Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
901000 usd
CY2023Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
2244000 usd
CY2022Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
81000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6235000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2473000 usd
CY2023Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
2150000 usd
CY2023Q2 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
41000 usd
CY2022Q2 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-272000 usd
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
229000 usd
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-608000 usd
CY2023Q2 lidr Common Stock Purchase Agreement Transaction Costs
CommonStockPurchaseAgreementTransactionCosts
0 usd
CY2022Q2 lidr Common Stock Purchase Agreement Transaction Costs
CommonStockPurchaseAgreementTransactionCosts
28000 usd
lidr Common Stock Purchase Agreement Transaction Costs
CommonStockPurchaseAgreementTransactionCosts
0 usd
lidr Common Stock Purchase Agreement Transaction Costs
CommonStockPurchaseAgreementTransactionCosts
28000 usd
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
47000 usd
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
17000 usd
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
14000 usd
CY2023Q2 lidr Interest Expense And Other Nonoperating Expense
InterestExpenseAndOtherNonoperatingExpense
11000 usd
CY2022Q2 lidr Interest Expense And Other Nonoperating Expense
InterestExpenseAndOtherNonoperatingExpense
307000 usd
lidr Interest Expense And Other Nonoperating Expense
InterestExpenseAndOtherNonoperatingExpense
-165000 usd
lidr Interest Expense And Other Nonoperating Expense
InterestExpenseAndOtherNonoperatingExpense
650000 usd
CY2023Q1 us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
469000 usd
CY2023Q2 us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
420000 usd
CY2022Q1 us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
-1056000 usd
CY2022Q2 us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
-182000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-16031000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-26467000 usd
us-gaap Net Income Loss
NetIncomeLoss
-42296000 usd
us-gaap Net Income Loss
NetIncomeLoss
-51348000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
175675994 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
157310419 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
168962722 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
156071676 shares
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2022Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
175675994 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
157310419 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
168962722 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
156071676 shares
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.25
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
64010836 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
64010836 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
48189376 shares
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
48189376 shares
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4110000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6557000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10623000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11897000 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P1Y18D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
1.045
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.048
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
571000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
706000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1207000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1788000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
571000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
706000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1207000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1788000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
150000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
987000 usd
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
150000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
987000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
987000 usd
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2918000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
837000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1285000 usd
lidr Contract With Customer Liability Increase For Invoice Issued On Performance Obligations Not Yet Satisfied
ContractWithCustomerLiabilityIncreaseForInvoiceIssuedOnPerformanceObligationsNotYetSatisfied
0 usd
lidr Contract With Customer Liability Increase For Invoice Issued On Performance Obligations Not Yet Satisfied
ContractWithCustomerLiabilityIncreaseForInvoiceIssuedOnPerformanceObligationsNotYetSatisfied
0 usd
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
150000 usd
CY2022Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1633000 usd
us-gaap Restructuring Charges
RestructuringCharges
1298000 usd
CY2022 us-gaap Restructuring Charges
RestructuringCharges
0 usd
CY2023Q2 us-gaap Restructuring Charges
RestructuringCharges
45000 usd
us-gaap Restructuring Charges
RestructuringCharges
1298000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26000 usd

Files In Submission

Name View Source Status
0001818644-23-000010-index-headers.html Edgar Link pending
0001818644-23-000010-index.html Edgar Link pending
0001818644-23-000010.txt Edgar Link pending
0001818644-23-000010-xbrl.zip Edgar Link pending
exhibit311ceosection302cer.htm Edgar Link pending
exhibit312cfosection302cer.htm Edgar Link pending
exhibit321section906certif.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lidr-20230630.htm Edgar Link pending
lidr-20230630.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
lidr-20230630_g1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
lidr-20230630_pre.xml Edgar Link unprocessable
lidr-20230630_htm.xml Edgar Link completed
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
lidr-20230630_cal.xml Edgar Link unprocessable
lidr-20230630_def.xml Edgar Link unprocessable
lidr-20230630_lab.xml Edgar Link unprocessable